Received Apr 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Boils; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of boil in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced boil (Verbatim: Boils). The outcome of the boil was not reported. It was unknown if the reporter considered the boil to be related to Shingrix. It was unknown if the company considered the boil to be related to Shingrix. Additional Information: GSK Receipt Date: 13-APR-2025 This case was reported by a patient via interactive digital media. The patient got the Shingrix vaccine and had boils The reporter asked can you develop boils after taken the vaccine. The case is 1 of the 6 linked case, by same reporter.; Sender's Comments: US-GSK-US2025AMR046237:same reporter US-GSK-US2025AMR046239:same reporter US-GSK-US2025AMR046242:same reporter US-GSK-US2025AMR046246:same reporter US-GSK-US2025AMR046250:same reporter